Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
01 1Pharmathen SA
01 1BRINZOLAMIDE
01 1Greece
01 1Active
01 1Complete
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
GDUFA
DMF Review : Complete
Rev. Date : 2019-12-06
Pay. Date : 2019-10-21
DMF Number : 34167
Submission : 2019-10-07
Status : Active
Type : II
20
Pharmathen Sa, based in Greece, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
One of their notable products is BRINZOLAMIDE, with a corresponding US DMF Number 34167.
Remarkably, this DMF maintains an Active status since its submission on October 07, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 06, 2019, and payment made on October 21, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
